
    
      Obese type 2 diabetes patients who were not treated with anti-diabetic medication within 6
      weeks, were randomly assigned to gemigliptin/metformin or sulphonylurea/metformin. After 24
      week treatment, gut microbiota composition change, glucose lowering effect, body weight, and
      gut hormones were compared between two groups.
    
  